Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 35, 2001 - Issue 1
Submit an article Journal homepage
9
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Management of Testicular Cancer: 16 years' Experience from Southwest Finland

J. Sundström, E. Salminen, M. Nurmi, J. Toppari, P. Pöllänen, L. J. Pelliniemi, S. Huhtala, P. Rajala, M. Laato Department of Anatomy and Laboratory of Electron Microscopy, University of Turku, Turku, Finland; Department of Oncology and Radiotherapy, University of Turku, Turku, Finland; Department of Surgery, University of Turku, Turku, Finland; Departments of Pediatrics and Physiology, University of Turku, Turku, Finland; Departments of Anatomy and of Obstetrics and Gynaecology, University of Turku, Turku, Finland; Laboratory of Electron Microscopy, University of Turku, Turku, Finland; Department of Biostatistics, University of Turku, Turku, Finland
Pages 21-25 | Published online: 09 Jul 2009

References

  • Adami HO, Bergström R, Miihner M, Zatonski W, Storm H, Ekbom A, et al. Testicular cancer in nine Northern European countries. Int J Cancer 1994; 59: 33–8.
  • Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075–107.
  • Gilliland FD, Key CR. Male genital cancers. Cancer 1995; 75 (Suppl): 295–315.
  • Finnish Cancer Registry Cancer incidence in Finland 1995. Vammala: Vammalan Kirjapaino; 1997: 8–30.
  • Einhorn LH. Testicular cancer: and oncological success story. Clin Cancer Res 1997; 3: 2630–2.
  • Kellokumpu-Lehtinen P, Halme A. Results of treatment in irradiated testicular seminoma patients. Radiother Oncol 1990; 18: 1–8.
  • Aareleid T, Sant M, Hedelin G, EUROCARE Working Group. Improved survival for patients with testicular cancer in Europe since 1978. Eur J Cancer 1998; 34: 2236–40.
  • Williams SD, Birch R, Irwin L, Greco A, Loehrer PJ, Einhorn LH. Disseminated germ cell tumors: chemother-apy with cisplatin plus bleomycin plus either vinblastine or etoposide. N Engl J Med 1987; 316: 1435–40.
  • Stiller CA. Comments and critique. Non-specialist units, clinical trials and survival from testicular cancer. Eur J Cancer 1995; 31A: 289–91.
  • Norum J, Nordoy T, Wist E. Testicular cancer treated in a minor general oncology department. Eur J Cancer 1995; 31A: 293–5.
  • Hartmann JT, Kanz L, Bokemeyer C. Diagnosis and treatment of patients with testicular germ cell cancer. Drugs 1999; 58: 257–81.
  • Mostofi FK, Sesterhenn IA Histological typing of testis tumours. 2nd ed. Berlin: Springer; 1998.
  • Cavalli F, Monfardini S, Pizzocaro G. Report on the international workshop on staging and treatment of testicular cancer. Eur J Cancer 1980; 16: 1367–72.
  • Toklu C, Ozen H, Sahin A, Rastadoskouee M, Erdem E. Factors involved in diagnostic delay of testicular cancer. Int Urol Nephrol 1999; 31: 383–8.
  • Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G. Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol 1998; 159: 855–8.
  • Hartmann JT, Kollmannsberger C, Kanz L, Bokemeyer C. Platinum organ toxicity and possible prevention in patients with testicular cancer. Int J Cancer 1999; 83: 866–9.
  • Cullen Mil, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, et al. Short-course adjuvant chemotherapy in high-risk stage I non-seminomatous germ cell tumours of the testis: a medical research council report. J Clin Oncol 1996; 14: 1106–13.
  • Pizzocaro G. Rationale for lymphadenectomy in stage I non-seminoma. In: Horwich A, editor. Testicular cancer. 2nd ed. London: Chapman and Hall Medical; 1996: 193–200.
  • Freedman LS, Parkinson MC, Jones WG, Oliver RT, Peckham MJ, Read G, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchiectomy alone. Lancet 1987; ii: 294–8.
  • Albers P, Siener R, Hartmann M, Weinknecht S, Schulze H, Rebmann U, et al. Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German multicenter trial. Int J Cancer 1999; 83: 828–30.
  • Gerl A, Clemm C, Schmeller N, Hentric M, Lamerz R, Wilmanns W. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 1997; 8: 41–7.
  • Howard GC, Clarke K, Elia MH, Hutcheon AW, Kaye SB, Windsor PM. A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ cell tumours. Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists. Br J Cancer 1995; 72: 1303–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.